Literature DB >> 6707375

Kinetics of thallium-201 in reperfused canine myocardium after coronary artery occlusion.

R D Okada.   

Abstract

To study the kinetics of thallium-201 in nonsalvaged acutely infarcted myocardium and salvaged myocardium, the tracer was administered after experimental left anterior descending coronary artery reperfusion 2 hours after occlusion. In 19 dogs, thallium activity was then monitored for 4 hours in the reperfused anterior wall and normal posterior wall using miniature cadmium telluride radiation detectors. After sacrifice, 13 of the dogs were found to have an infarcted anterior wall by triphenyltetrazolium-chloride staining. In these dogs, mean (+/- standard deviation) fractional 4 hour thallium clearance was 0.33 +/- 0.08 for the infarct zone and 0.15 +/- 0.06 for the normal control zone (p less than 0.001). When computer-modeled, the clearance curve from the infarct zone was biexponential. The second exponential clearance curve from the infarct zone began 19.1 +/- 3.2 minutes after tracer administration, and was indistinguishable from the monoexponential clearance curve from the normal control zone. Thallium clearance from the blood pool was triexponential, the final exponential clearance curve being indistinguishable from the normal control zone clearance curve. Six dogs were found to have a salvaged noninfarcted anterior wall by triphenyltetrazolium-chloride staining. In these dogs, mean fractional 4 hour thallium clearance was 0.20 +/- 0.07 for the reperfused zone, and 0.19 +/- 0.08 for the normal control zone (p = NS). When computer-modeled, clearance curves for the reperfused and control zones were monoexponential. The monoexponential clearance curve for the salvaged reperfused zone was indistinguishable from the monoexponential clearance curve for normal myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707375     DOI: 10.1016/s0735-1097(84)80183-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Reverse redistribution: is it clinically relevant or a washout?

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 3.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

4.  Serial Myocardial Imaging after a Single Dose of Thallium-201.

Authors:  Takahiko Kamata; Tatsuya Kawasaki; Tadaaki Kamitani; Hiroki Sugihara
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

5.  Comparison of thallium-201 SPECT redistribution patterns and rubidium-82 PET rest-stress myocardial blood flow imaging.

Authors:  R E Stewart; J Popma; G M Gacioch; M Kalus; S Squicciarini; Z al-Aouar; M A Schork; M Schwaiger
Journal:  Int J Card Imaging       Date:  1994-03

Review 6.  Reverse redistribution: fact or fiction?

Authors:  E M Dudzic; B S Sridhara; A Lahiri
Journal:  Eur J Nucl Med       Date:  1994-05

7.  Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201.

Authors:  N Takahashi; S T Dahlberg; M P Gilmore; J A Leppo
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

8.  Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.

Authors:  H Weinstein; C P Reinhardt; J F Wironen; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

9.  A Case of Isolated Septal Myocardial Infarction: Myocardial Perfusion-metabolism Mismatch as a Tool for Diagnosis.

Authors:  Kuniyasu Harimoto; Tatsuya Kawasaki; Sakiko Honda; Shota Kinoshita; Tadaaki Kamitani; Hiroki Sugihara
Journal:  Oman Med J       Date:  2019-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.